Skip to main content
Premium Trial:

Request an Annual Quote

Sequitur Renews and Expands Functional Genomics Contract with P&G

NEW YORK, May 23 - Sequitur has extended and expanded its functional genomics collaboration with Procter & Gamble Pharmaceuticals, the company said yesterday.

 

The agreement, extended beyond two years, will now cover additional therapeutic areas. Sequitur, based in Natick, Mass., will continue to perform biological screening and supply its antisense/RNAi compounds and methods to P&G for use in target validation studies.

 

According to Sequitur, the agreement is one of its largest collaborations.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.